LAUREN QUINN: Open Payments
NPI 1750793030 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $285 · 2025 $785
Food & beverage: $674Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $434 |
| Supernus Pharmaceuticals, Inc. | 1 | $124 |
| Alkermes, Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 1 | $106 |
Products named: UZEDY, Qelbree, LYBALVI, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across TX — which companies pay providers there.
